A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS.
Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5.
A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD).
Ng CG, Abousheishaa AA, Low SY, Zainal NZ, Thong KS, Awaluddin AB, Loo TH, Yacob SB, Nik Jaafar NR, Abdul Taib NIA, Mohamad Kamal NAB, Ismail F, Zamaniah Wi W.
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2583-2591. doi: 10.31557/APJCP.2023.24.8.2583.
A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders.
Kim S, Rush BS, Rice TR.
Eur Child Adolesc Psychiatry. 2021 Oct;30(10):1485-1501. doi: 10.1007/s00787-020-01542-3. Epub 2020 May 8.
Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial.
Coenen VA, Bewernick BH, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein ME, Spanier S, Sajonz B, Urbach H, Schlaepfer TE.
Neuropsychopharmacology. 2019 Jun;44(7):1224-1232. doi: 10.1038/s41386-019-0369-9. Epub 2019 Mar 13.
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.
Parikh SV, Vande Voort JL, Yocum AK, Achtyes E, Goes FS, Nykamp L, Singh B, Lopez-Vives D, Sera CE, Maixner D, Tarnal V, Severe J, Bartek S, Tye SJ, Rico J, Stoppel CJ, Becerra A, Smart L, Miller CR, Frye MA, Greden JF, Bobo WV.
J Affect Disord. 2024 Mar 1;348:143-151. doi: 10.1016/j.jad.2023.12.033. Epub 2023 Dec 22.
Traditional Chinese Acupuncture for Poststroke Depression: A Single-Blind Double-Simulated Randomized Controlled Trial.
Qian X, Zhou X, You Y, Shu S, Fang F, Huang S, Zhou S.
J Altern Complement Med. 2015 Dec;21(12):748-53. doi: 10.1089/acm.2015.0084. Epub 2015 Sep 18.
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, Aitchison KJ, Rietschel M.
World J Biol Psychiatry. 2011 Oct;12(7):528-38. doi: 10.3109/15622975.2011.559270. Epub 2011 Mar 9.
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr.
J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.
Discontinuation of antidepressant drugs during electroconvulsive therapy: a controlled study.
Mayur PM, Gangadhar BN, Subbakrishna DK, Janakiramaiah N.
J Affect Disord. 2000 Apr;58(1):37-41. doi: 10.1016/s0165-0327(99)00096-8.
Clinical research on the therapeutic effect of the electro-acupuncture treatment in patients with depression.
Luo H, Meng F, Jia Y, Zhao X.
Psychiatry Clin Neurosci. 1998 Dec;52 Suppl:S338-40. doi: 10.1111/j.1440-1819.1998.tb03262.x.
